Xcout Intel
Hawkhill Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Hawkhill Therapeutics among life sciences companies — ranked by similarity to what Hawkhill Therapeutics actually does, not by market-cap band.
Subscribe to see Hawkhill Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Hawkhill Therapeutics
Hawkhill Therapeutics Ltd is a biotech spin-out company from Tay Therapeutics based in Dundee, UK, focusing on scientific research and the delivery of new therapies.
Hawkhill Therapeutics at a glance
Hawkhill Therapeutics is a life sciences company headquartered in United Kingdom. Its most recent funding round raised $290,530 in April 2026. Xcout tracks 10 named people at Hawkhill Therapeutics, including Conor Woolfson (CFO/COO).
Hawkhill Therapeutics leadership
- Conor WoolfsonCFO/COO
- Dr Tim SpareyExecutive Chair
- Dr Andrew WoodlandCEO & Co-Founder
- Dr Mark BellCTO & Co-Founder
- Antoine BoulangerExecutive Officer
- Christopher Andrew WoodlandExecutive Officer
4 more named people on record for Hawkhill Therapeutics, with roles, board committees and tenure — see the full roster →
Hawkhill Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $290,530 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Hawkhill Therapeutics news
- FundingPrivate placement (Form D)
Top 12 Hawkhill Therapeutics competitors
Ranked by semantic similarity — how close each company is to Hawkhill Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Mironid Limited is a privately held drug discovery company founded in 2015 and headquartered in Glasgow, Scotland. The patient-focused company develops innovative therapeutics to improve the treatment of various medical conditions.
Biotechnology
Pathios Therapeutics Limited is a biotech company established in 2017 and registered in England and Wales, focusing on the discovery and development of first-in-class therapies.
Biotechnology
Apollo Therapeutics is a biopharmaceutical company with headquarters located in Cambridge, United Kingdom, alongside offices in Boston, Massachusetts. The company advances breakthrough science to build a portfolio of innovative therapeutics.
Biotechnology
NanoSyrinx Ltd. is a biotechnology company incorporated in England and Wales with headquarters in Warwick, focused on advancing targeted drug delivery platforms.
Biotechnology
Dunad Therapeutics is a transatlantic biotech company with operations in Cambridge, United Kingdom, and Boston in the United States. The company focuses on innovative therapeutics research and development with a small team of specialized scientists.
Biotechnology
Oak Hill Bio is a clinical-stage biotechnology company focused on acquiring and developing rare disease drugs that have been deprioritized by other organizations. Formed in 2024 as a subsidiary of Oak Hill Bio Holdings, the company operates under the trading name OHB Pediatrics Ltd and is headquartered in Altrincham, United Kingdom.
Biotechnology
Resolution Therapeutics is a biotechnology research company headquartered in Edinburgh, Scotland. The company is pioneering regenerative macrophage therapies to transform outcomes for people with inflammatory and fibrotic diseases.
Biotechnology
Volnay Therapeutics LLC is a privately held biotechnology research and holding company incorporated in Delaware, United States. The company focuses on drug discovery pipelines and therapeutic research.
Biotechnology
Portage Glasgow Limited is a joint venture established in partnership with the University of Glasgow to develop targeted drugs for chronic conditions. The company builds upon the university's expertise in precision medicine.
Biotechnology
Grey Wolf Therapeutics is a biotechnology company headquartered in the UK focused on delivering a new class of treatments to improve the lives of people with cancers and autoimmune disorders.
Biotech
Thalia Therapeutics Plc, a specialized pharmaceutical company established in 1979 and headquartered in Chellaston, UK, focuses on developing advanced nanoparticle silica delivery systems. These innovative systems are designed to enhance the cellular uptake and effectiveness of various cancer treatments and vaccines. The company's product portfolio includes Nuvec, a unique silica nanoparticle delivery platform distinguished by its irregular surface structure that effectively encapsulates and safeguards genetic material such as siRNA, RNA, and DNA. Additionally, it offers Liptide, a specialized platform engineered for the targeted delivery of a proprietary siRNA sequence to silence fibrotic genes. Thalia Therapeutics is also advancing N4 101, an orally administered inflammation inhibitor currently undergoing pre-clinical evaluation for the treatment of inflammatory bowel disease, alongside ECP105, which is being developed to prevent ocular scarring. The firm, previously known as N4 Pharma Plc, officially rebranded to Thalia Therapeutics Plc in March 2026.
Biotechnology
Graegis Pharmaceuticals Limited is a specialty pharmaceutical company headquartered in Cambridge, United Kingdom, operating from the Dorothy Hodgkin Building. It focuses on pharmaceutical research and development within the healthcare sector.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Hawkhill Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Hawkhill Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →